CDC Officials Unaware Recommendation On HPV Vaccination Would Lead To Immigration Mandate
Main Category: Cervical Cancer / HPV VaccineArticle Date: 02 Oct 2008 - 7:00 PDT
CDC officials said they were unaware that the agency's recommendation for young women to receive Merck's human papillomavirus vaccine Gardasil would lead to an immigration policy requiring immigrant women ages 11 to 26 to receive the vaccine, and an unnamed government official said the requirement might be reviewed, the Wall Street Journal reports (Jordan, Wall Street Journal, 10/1). The vaccine, approved by FDA two years ago and recommended by CDC's Advisory Committee on Immunization Practices, prevents transmission of HPV strains responsible for 70% of cervical cancer and 90% of genital warts (Daily Women's Health Policy Report, 9/30).
A 1996 immigration law states that any vaccination recommended by the U.S. government for its citizens becomes a required one for greencard applicants; Gardasil was added to an updated list of immigration vaccines in July and the policy went into effect Aug. 1. A spokeswoman for U.S. Citizenship and Immigration Services said the policy reflects "a statutory requirement" and is based on recommendations made by CDC.
However, some immigration advocates, physicians and experts said the policy is excessive and unfair to immigrants because of the high cost of the vaccine and research that questions its effectiveness. A CDC spokesperson said the experts on the immunization committee did not realize the decision would affect tens of thousands of immigrants. Jon Abramson, who was chair of ACIP when the recommendation was made, said requiring immigrants to receive the vaccine never was intended. If ACIP "had known about" the immigration requirement, the committee "would have said it's not a good idea," Abramson said, adding that HPV is a sexually transmitted infection and is "not something that endangers kids in a school setting or puts your population at risk."
Immigration advocates also are concerned about the cost of the vaccine for immigrants who already pay more than $500 in application fees. Gardasil requires a three-dose regimen, which costs $360, and the policy requires women 11 to 26 to get one dose of the vaccine, which costs around $120. Tuyet Duong, a senior staff attorney at the Asian American Justice Center, said the requirement is "outrageous" and is "creating an economic barrier" for female immigrants.
The U.S. government requires 14 vaccines for immigration, 13 of which are aimed at combating infectious diseases that are transmitted by respiratory routes and considered to be highly contagious. Gardasil is the only STI on the list. A spokesperson for Merck in a statement said that the company was unaware of the policy, adding that the company "did not lobby for this provision in any way" (Wall Street Journal, 10/1).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2008 The Advisory Board Company. All rights reserved.
Visit our cervical cancer / hpv vaccine section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/123892.php>
APA
http://www.medicalnewstoday.com/releases/123892.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
Gardasil - Safety?
posted by Grace Filby on 3 Oct 2008 at 12:44 amWe still don't know the safety of this vaccine! Surely it's much too soon and far too risky to have an immigration mandate?
Certainly there are growing numbers - thousands of reports of serious adverse effects, and the CDC website refers to 21 reported deaths although a causal link with Gardasil is unproven as yet.
Please note: the MediLexicon link on Gardasil states the following and also please note, we will not know the outcome for one whole year......... Are all these girls being used as guinea pigs?
Merck commits to conduct a short-term safety surveillance study in a U.S. Managed Care Organization (MCO). The study will include approximately 44,000 vaccinated subjects who will be followed for 60 days for assessment of general short-term safety (i.e., emergency room visits, hospitalizations, and deaths). The subjects will also be followed for 6 months subsequent to vaccination for new autoimmune disorders, rheumatologic conditions, or thyroiditis. Also, a sufficient number of children 11-12 years of age will be studied to permit an analysis of safety outcomes.
Final Study Protocol Submission: December 31, 2006
Enrollment Completion: December 31, 2008
Study Completion: June 30, 2009
Final Study Report: September 30, 2009
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




